PMID- 27289045 OWN - NLM STAT- MEDLINE DCOM- 20170822 LR - 20210816 IS - 1879-1220 (Electronic) IS - 0960-0760 (Linking) VI - 172 DP - 2017 Sep TI - Merlin, the product of NF2 gene, is associated with aromatase expression and estrogen formation in human liver tissues and liver cancer cells. PG - 222-230 LID - S0960-0760(16)30153-4 [pii] LID - 10.1016/j.jsbmb.2016.05.023 [doi] AB - The product of neurofibromatosis type 2 (NF2) gene, also known as Merlin/neurofibromin 2, homeostatically regulates liver stem cells by controlling abundance and signaling of epidermal growth factor receptor (EGFR), with a mechanism independent of the Hippo pathway. We have reported that locally elevated estrogen formation, driven by abnormally high expression and function of aromatase, may be implicated in development and progression of human hepatocellular carcinoma (HCC) through activation of a rapid signaling pathway mediated by amphiregulin (AREG) and EGFR. We have recently presented a model by which the aromatase-estrogen-amphiregulin-EGFR axis is activated in response to tissue injury and/or inflammatory disease, with its alteration eventually leading to development of major human tumors (liver, breast, prostate) and other chronic diseases (diabetes, obesity, Alzheimer's and heart disease). In this study, we investigated NF2 expression in liver cancer cells and tissues in relation to aromatase expression/function, estrogen receptor (ER) status and amphiregulin. Our data indicate that NF2 expression is associated with aromatase and AREG expression, being elevated in HCC tissues and HepG2 cells, intermediate in cirrhotic tissues and Huh7 cells, and lower in nontumoral liver and HA22T cells. In addition, NF2 expression is inversely related to wild type hERalpha66 and proportional to the expression of the membrane-associated hERalpha36 splice variant, as measured by exon-specific RT-PCR analysis, both in vivo and in vitro. Furthermore, incubation with estradiol induced a significant decrease of NF2 expression in both HA22T and Huh7 cells (over 54% and 22%, respectively), while no change could be observed in HepG2 cells, this effect being inversely related to aromatase expression and activity in HCC cell lines. Based on the above combined evidence, we hypothesize that NF2 behaves as a protein sensing tissue damage and aromatase-driven local estrogen formation, eventually leading to regulation of stem cells differentiation and tissue repair. CI - Copyright (c) 2016 Elsevier Ltd. All rights reserved. FAU - Cocciadiferro, Letizia AU - Cocciadiferro L AD - Unit of Research & Internationalization, ARNAS-Civico Di Cristina Benfratelli (ARNAS-CDB), Piazzale N. Leotta 2, 90127 Palermo, Italy. Electronic address: leticoccia@libero.it. FAU - Miceli, Vitale AU - Miceli V AD - Department of Laboratory Medicine and Advanced Biotechnologies, IRCCS-ISMETT (Istituto Mediterraneo per i Trapianti e Terapie ad alta specializzazione), Via Tricomi 5, 90127 Palermo, Italy. Electronic address: vmiceli@ismett.edu. FAU - Granata, Orazia M AU - Granata OM AD - Unit of Clinical Pathology, "G. Di Cristina" Children Hospital, ARNAS-CDB, Via dei Benedettini 1, 90127 Palermo, Italy. Electronic address: oraziamaria.granata@arnascivico.it. FAU - Carruba, Giuseppe AU - Carruba G AD - Unit of Research & Internationalization, ARNAS-Civico Di Cristina Benfratelli (ARNAS-CDB), Piazzale N. Leotta 2, 90127 Palermo, Italy. Electronic address: giuseppe.carruba@arnascivico.it. LA - eng PT - Journal Article PT - Review DEP - 20160608 PL - England TA - J Steroid Biochem Mol Biol JT - The Journal of steroid biochemistry and molecular biology JID - 9015483 RN - 0 (AREG protein, human) RN - 0 (Amphiregulin) RN - 0 (ESR1 protein, human) RN - 0 (Estrogen Receptor alpha) RN - 0 (Protein Isoforms) RN - 4TI98Z838E (Estradiol) RN - EC 1.14.14.1 (Aromatase) RN - EC 2.7.10.1 (EGFR protein, human) RN - EC 2.7.10.1 (ErbB Receptors) SB - IM MH - Alternative Splicing MH - Amphiregulin/genetics/metabolism MH - Aromatase/*genetics/metabolism MH - Carcinoma, Hepatocellular/*genetics/metabolism/pathology MH - ErbB Receptors/genetics/metabolism MH - Estradiol/metabolism/pharmacology MH - Estrogen Receptor alpha/genetics/metabolism MH - *Gene Expression Regulation, Neoplastic MH - Hep G2 Cells MH - Humans MH - Liver/drug effects/metabolism/pathology MH - Liver Neoplasms/*genetics/metabolism/pathology MH - Neoplastic Stem Cells/drug effects/*metabolism/pathology MH - Neurofibromatosis 2/*genetics/metabolism MH - Protein Isoforms/genetics/metabolism MH - Signal Transduction OTO - NOTNLM OT - Amphiregulin OT - Aromatase OT - Estrogen receptors OT - Hepatocellular carcinoma OT - Merlin EDAT- 2016/06/12 06:00 MHDA- 2017/08/23 06:00 CRDT- 2016/06/12 06:00 PHST- 2016/05/24 00:00 [received] PHST- 2016/05/29 00:00 [revised] PHST- 2016/05/31 00:00 [accepted] PHST- 2016/06/12 06:00 [pubmed] PHST- 2017/08/23 06:00 [medline] PHST- 2016/06/12 06:00 [entrez] AID - S0960-0760(16)30153-4 [pii] AID - 10.1016/j.jsbmb.2016.05.023 [doi] PST - ppublish SO - J Steroid Biochem Mol Biol. 2017 Sep;172:222-230. doi: 10.1016/j.jsbmb.2016.05.023. Epub 2016 Jun 8.